- Home
- DVAX vs MTTR Comparison
DVAX vs MTTR Comparison
Compare DVAX & MTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- MTTR
- Stock Information
- Founded
- DVAX 1996
- MTTR 2011
- Country
- DVAX United States
- MTTR United States
- Employees
- DVAX N/A
- MTTR N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- MTTR Computer Software: Prepackaged Software
- Sector
- DVAX Health Care
- MTTR Technology
- Exchange
- DVAX Nasdaq
- MTTR Nasdaq
- Market Cap
- DVAX 1.7B
- MTTR 1.6B
- IPO Year
- DVAX 2004
- MTTR N/A
- Fundamental
- Price
- DVAX $12.45
- MTTR $5.14
- Analyst Decision
- DVAX Buy
- MTTR Hold
- Analyst Count
- DVAX 2
- MTTR 4
- Target Price
- DVAX $23.00
- MTTR $5.13
- AVG Volume (30 Days)
- DVAX 1.8M
- MTTR 3.5M
- Earning Date
- DVAX 02-20-2025
- MTTR 02-18-2025
- Dividend Yield
- DVAX N/A
- MTTR N/A
- EPS Growth
- DVAX N/A
- MTTR N/A
- EPS
- DVAX 0.15
- MTTR N/A
- Revenue
- DVAX $260,810,000.00
- MTTR $165,426,000.00
- Revenue This Year
- DVAX $21.64
- MTTR $10.33
- Revenue Next Year
- DVAX $19.81
- MTTR $11.92
- P/E Ratio
- DVAX $82.38
- MTTR N/A
- Revenue Growth
- DVAX N/A
- MTTR 3.82
- 52 Week Low
- DVAX $9.74
- MTTR $1.73
- 52 Week High
- DVAX $14.30
- MTTR $5.17
- Technical
- Relative Strength Index (RSI)
- DVAX 41.74
- MTTR 67.35
- Support Level
- DVAX $12.27
- MTTR $4.70
- Resistance Level
- DVAX $12.74
- MTTR $5.08
- Average True Range (ATR)
- DVAX 0.35
- MTTR 0.11
- MACD
- DVAX -0.06
- MTTR 0.03
- Stochastic Oscillator
- DVAX 37.39
- MTTR 94.12
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About MTTR Matterport Inc.
Matterport Inc is a spatial data company focused on digitizing and indexing the built world. Its all-in-one 3D data platform enables anyone to turn a space into an accurate and immersive digital twin which can be used to design, build, operate, promote, and understand any space. The Company recognizes revenue from subscription, license, services and sale of products. Majority of the revenue is generated in the form of subscription fees which it receives from the customers for providing them access to Matterport platform.